What is ATTAC?
The ‘Antigen-Targeted Therapy Against Cancer (‘ATTAC’) program is an Australian-based collaborative program for the delivery of personalised mutation-based cancer vaccines that ‘wake up’ the body’s immune system and force it to attack and destroy mutation-bearing cancer cells with ‘laser-like precision’. It could be a game-changer for cancer patients, regardless of cancer type.
Clinical trials using such vaccines as cancer immunotherapy have begun. We do not know how effective they will be, but our program will help to find that out.
